Clear Solutions Biomedical
Clear Solutions Biomedical, led by Glenn D. Prestwich, Ph.D., specializes in providing expert witness and consulting services at the interface of law, intellectual property, and the chemical and life sciences. The company leverages broad scientific expertise, including chemistry, biochemistry, biology, bioengineering, medical devices, and pharmaceuticals, to deliver clear, credible, and jury-friendly scientific opinions. It also has a strong focus on intellectual property, with Dr. Prestwich being an inventor on over 90 patents and patent applications, and has extensive experience in courtroom testimony and patent law. The company's mission is to help clients understand complex scientific issues and translate laboratory ideas into products that improve lives.
Industries
Nr. of Employees
small (1-50)
Services
Preparation of declarations, affidavits, technical reports, deposition preparation, and courtroom testimony for patent and technical disputes in chemical and life sciences.
Collaboration with inventors and attorneys on patent preparation, prosecution support, and IP portfolio development tailored to translational technologies.
Advisory service on writing and structuring grant proposals and funding strategies for non-dilutive and dilutive support.
Technical consulting on development and preclinical evaluation of biomaterials, hyaluronan-derived hydrogels, and glycosaminoglycan-based therapeutics to support product translation.
Coaching and services to prepare technical experts for clear, non‑technical communication in reports, depositions, and courtroom testimony.
Preparation of declarations, affidavits, technical reports, deposition preparation, and courtroom testimony for patent and technical disputes in chemical and life sciences.
Collaboration with inventors and attorneys on patent preparation, prosecution support, and IP portfolio development tailored to translational technologies.
Advisory service on writing and structuring grant proposals and funding strategies for non-dilutive and dilutive support.
Technical consulting on development and preclinical evaluation of biomaterials, hyaluronan-derived hydrogels, and glycosaminoglycan-based therapeutics to support product translation.
Coaching and services to prepare technical experts for clear, non‑technical communication in reports, depositions, and courtroom testimony.
Expertise Areas
- Expert witness services and litigation support
- Patent analysis and intellectual property strategy
- Organic and medicinal chemistry
- Biomaterials and regenerative medicine
Key Technologies
- Hyaluronic acid-based hydrogels
- Glycosaminoglycan derivatives (semisynthetic SAGEs)
- Affinity probes for phosphoinositides and lysolipids
- Photoaffinity labeling
News & Updates
Expert Witness Experience in Court Cases
Dr. Prestwich has provided expert testimony in over 16 cases since 2007, including patent disputes, false advertising, and drug delivery cases.
Recent Publications and Patents
Over 650 publications and 90 patents, with research spanning anti-cancer drugs, wound repair gels, cell therapy, insect control agents, cholesterol-lowering agents, and more.
Research in Regenerative Medicine and Drug Discovery
Development of hyaluronan-based biomaterials, phosphoinositide signaling tools, and sulfated glycosaminoglycans for therapeutic applications.
Chemically Modified Hyaluronan for Regenerative Medicine
Over 23 years of research on hyaluronan chemistry and biology, leading to patents and translational products in wound healing, cell therapy, and surgical adhesion prevention.
Cell Signaling Probes and Lipid Analogs
Development of affinity probes for phosphoinositide and lysolipid binding proteins, leading to commercial reagents and tools for cell signaling and drug discovery.
Translational Medicine of Sulfated Glycosaminoglycans
Research on semisynthetic glycosaminoglycan ethers (SAGEs) for inflammatory diseases, including periodontal disease, interstitial cystitis, and mucositis.
Expert Witness Experience in Court Cases
Dr. Prestwich has provided expert testimony in over 16 cases since 2007, including patent disputes, false advertising, and drug delivery cases.
Recent Publications and Patents
Over 650 publications and 90 patents, with research spanning anti-cancer drugs, wound repair gels, cell therapy, insect control agents, cholesterol-lowering agents, and more.
Research in Regenerative Medicine and Drug Discovery
Development of hyaluronan-based biomaterials, phosphoinositide signaling tools, and sulfated glycosaminoglycans for therapeutic applications.
Chemically Modified Hyaluronan for Regenerative Medicine
Over 23 years of research on hyaluronan chemistry and biology, leading to patents and translational products in wound healing, cell therapy, and surgical adhesion prevention.
Cell Signaling Probes and Lipid Analogs
Development of affinity probes for phosphoinositide and lysolipid binding proteins, leading to commercial reagents and tools for cell signaling and drug discovery.
Translational Medicine of Sulfated Glycosaminoglycans
Research on semisynthetic glycosaminoglycan ethers (SAGEs) for inflammatory diseases, including periodontal disease, interstitial cystitis, and mucositis.